Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF June 6, 2014 | Archived Issues

Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - June 2014 (PDF)


Milestones

Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue. Click here to email us your milestones and comments.

Click the "Read more" link to see this issue's milestones.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Update on Shortages of Nitroglycerin Inj, Metronidazole Inj

Cedars-Sinai is experiencing an ongoing shortage of nitroglycerin inj. The shortage of commercial, premade nitroglycerin 50 mg/250 mL infusion bottles has resolved. Premade nitroglycerin 50 mg/250 mL infusion bottles will be restocked in 4 North Saperstein and 6 Saperstein at standard par levels. New nitroglycerin infusion orders will be processed as written.

Nitroglycerin 5mg/ml x 10ml vials remain unavailable. At this time, we cannot accommodate custom nitroglycerin infusion (i.e., nitroglycerin infusion in normal saline or different concentrations).

Metronidazole Inj Shortage

Cedars-Sinai also is experiencing an ongoing shortage of metronidazole inj. To conserve the remaining supply, the following automatic substitution has been implemented.

Medication OrderedAutomatic Substitution
Metronidazole injMetronidazole PO, same dose and frequency if patient is able to tolerate orals except when used for treatment of brain abscess, meningitis, anaerobic bacteremia, severe complicated C. difficile infection

This plan was approved by the Antimicrobial Use Review Committee and the Pharmacy and Therapeutics Committee.